Semantic Scholar uses AI to extract papers important to this topic.
Current approaches to diagnosing testosterone deficiency do not consider the physiological consequences of various… Expand BACKGROUND
We did a randomised phase 3 trial assessing the benefit of addition of long-term androgen suppression with a… Expand Androgen deprivation as a treatment for prostate cancer has evolved since the pioneering studies of Huggins and Hodges 60 years… Expand This Gynecologic Oncology Group (GOG) study was designed to estimate the activity of goserelin acetate as treatment for advanced… Expand Following identification of the proportion of pelvic congestion among symptomatic patients complaining of chronic pelvic pain… Expand PURPOSE
Nonsteroidal antiandrogen monotherapy may be a treatment option for some patients with advanced prostate cancer. We… Expand Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The… Expand OBJECTIVE
To confirm the advantages of goserelin prior to endometrial ablation for the treatment of dysfunctional uterine… Expand Background. Since postcastration progression of tumors to an androgen‐independent state appears to be linked to the cessation of… Expand Maximal androgen blockade (MAB), the eradication of the effects of adrenal androgens on prostate cancer cells after castration… Expand